Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04844749
Title Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent (VERU-111)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Veru Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.